Αποτελέσματα Αναζήτησης
19 Ιουν 2020 · In general, the optimal treatment of both acute and chronic pain requires an individualized approach that involves interdisciplinary care. This approach encompasses pharmacological, nonpharmacological, and integrative therapeutic interventions that are tailored to individual patient needs.
25 Φεβ 2024 · Implement evidence-based treatment and management options available for sickle cell crisis. Develop interprofessional team strategies for improving care coordination to manage sickle cell crises and improve outcomes. Access free multiple choice questions on this topic.
16 Απρ 2020 · These evidence-based guidelines of the American Society of Hematology are intended to support the SCD community in decisions about prevention, diagnosis, and treatment of the most common neurological morbidities in SCD.
3 Μαρ 2022 · In this review, we discuss advances in the diagnosis and management of four major complications: acute and chronic pain, cardiopulmonary disease, central nervous system disease and kidney disease. We also discuss advances in disease-modifying and curative therapeutic options for SCD.
Multiple other drugs (L-glutamine, crizanlizumab, and voxelotor) have recently been approved for the treatment of SCD, with several others at various stages of clinical testing.
Liberalized use of blood transfusions and early consideration of hydroxyurea treatment represent a new treatment paradigm for SCA management. Children with untreated sickle cell anemia typically die young.
Early diagnosis, treatment, and prevention of a vaso-occlusive crisis (VOC) are critical to the management of patients with sickle cell disease. It is essential to differentiate between VOC-associated pain and chronic pain, hyperalgesia, neuropathy, and neuropathic pain.
